IKS Health Q2 revenue rises 103.9% on TruBridge consolidation

Inventurus Knowledge Solutions Limited, operating as IKS Health, reported Q2 FY27 revenue of Rs 1,592.5 crore for the quarter ended September 30, 2026, up 103.9% year on year after consolidating 82 days of TruBridge operations. EBITDA rose 62.5% to Rs 441.5 crore, while IKS Health said the acquisition was accretive to profit after tax and earnings per share from its first consolidated quarter.

How did IKS Health perform in Q2 FY27?

IKS Health more than doubled revenue in Q2 FY27, reporting Rs 1,592.5 crore for the quarter ended September 30, 2026, compared with Rs 781.1 crore in Q2 FY26. Revenue also increased 78.2% sequentially from Rs 893.6 crore in Q1 FY27. In US dollar terms, the company reported 87.3% year-on-year revenue growth, below the 103.9% increase reported in Indian rupees.

EBITDA, or earnings before interest, tax, depreciation and amortisation, rose to Rs 441.5 crore from Rs 271.8 crore a year earlier and Rs 294.9 crore in Q1 FY27. That represented growth of 62.5% year on year and 49.7% quarter on quarter. The reported EBITDA margin was 27.7% in the September 2026 quarter.

Profit after tax, or PAT, was Rs 217.7 crore in Q2 FY27, increasing 20.4% from Rs 180.7 crore in Q2 FY26 and 12.4% from Rs 193.7 crore in Q1 FY27. PAT therefore grew more slowly than revenue and EBITDA in both comparisons. IKS Health reported a PAT margin of 13.7% for Q2 FY27.

Did TruBridge add to IKS Health earnings in Q2 FY27?

IKS Health said the TruBridge acquisition was accretive to PAT and earnings per share, or EPS, from Q2 FY27, its first consolidated quarter for the acquired business. The September 2026 quarter included 82 days of TruBridge consolidation, which IKS Health cited alongside continued care-enablement platform momentum in reporting revenue of Rs 1,592.5 crore.

Group Chief Financial Officer Nithya Balasubramanian said the 78.2% sequential increase in Q2 FY27 revenue reflected early financial accretion from the TruBridge integration as well as sustained organic revenue momentum. She also said operating discipline supported EBITDA conversion as IKS Health scaled. The release did not provide separate TruBridge revenue, profit, purchase-price or synergy figures for the 82-day period.

Founder and Global Chief Executive Officer Sachin K. Gupta said Q2 FY27 marked the start of operationalising the combined strengths of IKS Health and TruBridge. His stated objective is to build an artificial intelligence-native operating system for healthcare that enables clinical enterprises to transform operations, accelerate revenue and cash generation, improve care quality and pursue financial sustainability.

What drove IKS Health revenue momentum?

IKS Health attributed Q2 FY27 momentum to expanded work with existing clients, new account wins and cross-selling, according to Gupta. The company linked its 103.9% year-on-year revenue increase to momentum across its care-enablement platform and the 82-day TruBridge consolidation. It did not quantify the respective contribution of organic activity and the acquired business.

A new partnership with White-Wilson Medical Center in Northwest Florida covers end-to-end revenue cycle management, or RCM, and scheduling. White-Wilson is a large multi-specialty group providing primary, specialty, imaging and laboratory care. IKS Health said the partnership establishes it as a growth partner as White-Wilson scales clinical support and value-based care.

At Evolve Orthopedic Partners, a physician-led New York-based orthopaedic and ambulatory surgery centre management services organisation, IKS Health provides end-to-end RCM services. Implementation is under way for MyCareHub, IKS Health’s intelligent patient-access platform, at OrthoNY. The planned deployment is intended to transform front-end operations across the specialty practice.

Which customer engagements did IKS Health disclose?

IKS Health said its existing work with Augusta Health includes electronic health record data migration, validation, orthopaedic migration support and document processing. A proposed expansion into coverage verification would extend this work into ongoing RCM support in Augusta Health’s new electronic medical record workflows. IKS Health described the coverage-verification expansion as proposed rather than completed.

At UMass Memorial Health, described by IKS Health as Central Massachusetts’ largest not-for-profit system and a partner of UMass Chan Medical School, its Migrate product is consolidating legacy records into the Epic environment after the Milford Regional integration. The project is expanding to the parent enterprise. IKS Health said this could establish a repeatable model for future integrations.

TruBridge has separately partnered with MISH Hospital & Clinics, a specialty surgical hospital in Lenexa, Kansas, serving the Kansas City region. MISH is to implement a unified electronic health record platform combining patient information and clinical workflows in one system. IKS Health said the platform is intended to streamline operations, improve access, reduce technology complexity and support coordinated care.

What is IKS Health focusing on after the TruBridge deal?

IKS Health said its focus in the coming quarters will be on realising operational synergies from the TruBridge integration, strengthening return profiles and driving sustainable long-term shareholder value. This plan follows the first 82 days of consolidation included in Q2 FY27. The November 5, 2026 release also cautioned that statements on future growth prospects involve risks and uncertainties.

The next reported periods will indicate progress against that integration plan after Q2 FY27 revenue of Rs 1,592.5 crore and a 27.7% EBITDA margin. The release provides no quantified target for synergies, margins, revenue, PAT or EPS. It also provides no timetable for Augusta Health’s proposed coverage-verification expansion.

Conclusion

IKS Health’s Q2 FY27 results show a substantial change in reported scale, with revenue rising 103.9% year on year to Rs 1,592.5 crore and 78.2% from Q1 FY27. EBITDA reached Rs 441.5 crore, while PAT increased at a lower 20.4% annual rate to Rs 217.7 crore. Management said TruBridge was accretive to PAT and EPS from the first consolidated quarter.

The next development to watch is IKS Health’s stated plan to realise TruBridge operational synergies in coming quarters, alongside implementation of MyCareHub at OrthoNY and the unified electronic health record platform at MISH Hospital & Clinics. The company has not disclosed quantified integration benefits or a timetable for the proposed Augusta Health coverage-verification work.